Search

Search Constraints

You searched for: Author/Creator Gilbert, Sarah C.

Search Results

1. Activation of cross-reactive mucosal T and B cell responses in human nasopharynx-associated lymphoid tissue in vitro by Modified Vaccinia Ankara-vectored influenza vaccines. Issue 14 (29th March 2016)

3. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Issue 30 (27th June 2017)

4. ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice. Issue 30 (27th June 2017)

6. Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoter. Issue 1 (2nd January 2016)

7. Improved adjuvanting of seasonal influenza vaccines: Preclinical studies of MVA‐NP+M1 coadministration with inactivated influenza vaccine. Issue 7 (10th June 2013)

8. Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report. Issue 1 (2nd October 2022)

9. Manufacturing a chimpanzee adenovirus‐vectored SARS‐CoV‐2 vaccine to meet global needs. Issue 1 (15th November 2021)

10. Production of a high purity, C‐tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditions. Issue 10 (22nd July 2022)